BENEVICH ERIC 内部人交易：近期 SEC Form 4 交易
过去 18 个月，BENEVICH ERIC（CIK 1643653）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-09-15）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 6,275 | $0 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 3,386 | $528,961 |
| 2026-09-10 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 3,194 | $138,109 |
| 2026-09-10 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 2,154 | $333,030 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 2,005 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 1,082 | $133,194 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 1,961 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 1,058 | $131,319 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 2,083 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 1,124 | $139,511 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 16,613 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 8,963 | $1.1M |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 2,294 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 1,292 | $175,790 |
| 2026-01-16 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 12,830 | $461,752 |
| 2025-12-02 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 买入 | 5,970 | $214,860 |
| 2025-12-02 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | 卖出 | 5,970 | $905,888 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15